Novel insights into the function of CD24: a driving force in cancer

CD24 is a highly glycosylated protein with a small protein core that is linked to the plasma membrane via a glycosyl-phosphatidylinositol anchor. CD24 is primarily expressed by immune cells but is often overexpressed in human tumors. In cancer, CD24 is a regulator of cell migration, invasion and pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Altevogt, Peter (Author) , Hüser, Laura (Author)
Other Authors: Sammar, Marei (Other) , Kristiansen, Glen (Other)
Format: Article (Journal)
Language:English
Published: 2021
In: International journal of cancer
Year: 2020, Volume: 148, Issue: 3, Pages: 546-559
ISSN:1097-0215
DOI:10.1002/ijc.33249
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/ijc.33249
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.33249
Get full text
Author Notes:Peter Altevogt, Marei Sammar, Laura Hüser, Glen Kristiansen

MARC

LEADER 00000caa a2200000 c 4500
001 175479257X
003 DE-627
005 20220819164018.0
007 cr uuu---uuuuu
008 210414r20212020xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.33249  |2 doi 
035 |a (DE-627)175479257X 
035 |a (DE-599)KXP175479257X 
035 |a (OCoLC)1341404529 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Altevogt, Peter  |d 1947-  |e VerfasserIn  |0 (DE-588)1113206306  |0 (DE-627)867118784  |0 (DE-576)164729240  |4 aut 
245 1 0 |a Novel insights into the function of CD24  |b a driving force in cancer  |c Peter Altevogt, Marei Sammar, Laura Hüser, Glen Kristiansen 
264 1 |c 2021 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.04.2021 
500 |a First published: 13 August 2020 
520 |a CD24 is a highly glycosylated protein with a small protein core that is linked to the plasma membrane via a glycosyl-phosphatidylinositol anchor. CD24 is primarily expressed by immune cells but is often overexpressed in human tumors. In cancer, CD24 is a regulator of cell migration, invasion and proliferation. Its expression is associated with poor prognosis and it is used as cancer stemness marker. Recently, CD24 on tumor cells was identified as a phagocytic inhibitor (“do not eat me” signal) having a suppressive role in tumor immunity via binding to Siglec-10 on macrophages. This finding is reminiscent of the demonstration that soluble CD24-Fc can dampen the immune system in autoimmune disease. In the present review, we summarize recent progress on the role of the CD24-Siglec-10 binding axis at the interface between tumor cells and the immune system, and the role of CD24 genetic polymorphisms in cancer. We describe the specific function of cytoplasmic CD24 and discuss the presence of CD24 on tumor-released extracellular vesicles. Finally, we evaluate the potential of CD24-based immunotherapy. 
534 |c 2020 
650 4 |a carbohydrates 
650 4 |a CD24 
650 4 |a extracellular vesicles 
650 4 |a Fc fusion proteins 
650 4 |a phagocytosis 
650 4 |a selectins 
650 4 |a Siglecs 
700 1 |a Sammar, Marei  |4 oth 
700 1 |a Hüser, Laura  |d 1989-  |e VerfasserIn  |0 (DE-588)1160493715  |0 (DE-627)1023730499  |0 (DE-576)505948931  |4 aut 
700 1 |a Kristiansen, Glen  |4 oth 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 148(2021), 3, Seite 546-559  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a Novel insights into the function of CD24 a driving force in cancer 
773 1 8 |g volume:148  |g year:2021  |g number:3  |g pages:546-559  |g extent:14  |a Novel insights into the function of CD24 a driving force in cancer 
856 4 0 |u https://doi.org/10.1002/ijc.33249  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.33249  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210414 
993 |a Article 
994 |a 2021 
998 |g 1160493715  |a Hüser, Laura  |m 1160493715:Hüser, Laura  |d 60000  |d 61900  |e 60000PH1160493715  |e 61900PH1160493715  |k 0/60000/  |k 1/60000/61900/  |p 3 
998 |g 1113206306  |a Altevogt, Peter  |m 1113206306:Altevogt, Peter  |d 60000  |d 61900  |d 50000  |e 60000PA1113206306  |e 61900PA1113206306  |e 50000PA1113206306  |k 0/60000/  |k 1/60000/61900/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN175479257X  |e 3909222706 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 14.04.2021","First published: 13 August 2020"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"175479257X","person":[{"roleDisplay":"VerfasserIn","display":"Altevogt, Peter","role":"aut","family":"Altevogt","given":"Peter"},{"given":"Marei","family":"Sammar","role":"oth","display":"Sammar, Marei"},{"family":"Hüser","given":"Laura","roleDisplay":"VerfasserIn","display":"Hüser, Laura","role":"aut"},{"given":"Glen","family":"Kristiansen","role":"oth","display":"Kristiansen, Glen"}],"title":[{"title_sort":"Novel insights into the function of CD24","title":"Novel insights into the function of CD24","subtitle":"a driving force in cancer"}],"physDesc":[{"extent":"14 S."}],"relHost":[{"id":{"issn":["1097-0215"],"zdb":["1474822-8"],"doi":["10.1002/(ISSN)1097-0215"],"eki":["269532781"]},"origin":[{"publisherPlace":"Bognor Regis","dateIssuedDisp":"1966-","publisher":"Wiley-Liss","dateIssuedKey":"1966"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title":"International journal of cancer"}],"recId":"269532781","language":["eng"],"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"International Union against Cancer"}],"disp":"Novel insights into the function of CD24 a driving force in cancerInternational journal of cancer","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"titleAlt":[{"title":"Predictive oncology"}],"part":{"extent":"14","volume":"148","text":"148(2021), 3, Seite 546-559","pages":"546-559","issue":"3","year":"2021"},"pubHistory":["1.1966 -"],"titleTranslated":[{"translated":"Journal international du cancer"}]}],"name":{"displayForm":["Peter Altevogt, Marei Sammar, Laura Hüser, Glen Kristiansen"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"2021"}],"id":{"eki":["175479257X"],"doi":["10.1002/ijc.33249"]}} 
SRT |a ALTEVOGTPENOVELINSIG2021